Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva Stares Into Abyss as It Slashes Forecast, Dividends - Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva's Working With Evercore to Review Debt Options - Bloomberg
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
The Difficulties of Cloning a CEO - Bloomberg
Teva: Now What? | Barron's
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Considering Cutting up to 10,000 Jobs: Bloomberg
With New Teva Deal, Combined NY Settlements With Opioid Makers Top $2 Billion | New York Law Journal
Teva Pharmaceutical: Value at Last - WSJ
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Justice Dept reportedly may file charges in its generic-drug probe by year-end
Teva CEO Steps Down After Patent Losses, Bribery Settlement; Stock Dives | Stock News & Stock Market Analysis - IBD
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
